HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medication Errors: FDA Renews Focus On Drug Packaging As Part Of Prevention Campaign

This article was originally published in The Pink Sheet Daily

Executive Summary

June workshop is first step in development of a guidance addressing what drug developers can do to reduce mistakes.
Advertisement

Related Content

Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Transcept Aims To Refile Intermezzo Insomnia NDA In Late Q4 With Highway Driving Data
Regulatory News In Brief
FDA Launches Safe Use Initiative; Details To Evolve Through Stakeholder Input
FDA Launches Safe Use Initiative; Details To Evolve Through Stakeholder Input

Topics

Advertisement
UsernamePublicRestriction

Register

PS070474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel